Analyst Ratings for Synta Pharma. (SNTA) [Neutrals]

SNTA Rating Summary

SNTA Price Target Summary

  |   Expand Research on SNTA
Overall Rating: BUY   Rating Trend: Down   Avg. $ Target: $11.86 (+60.4%)
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
5/7/2013 BMO Capital Downgrade Market Perform
(Outperform)
9.00
(18.00)
9.37 7.39 -21.13% Details
4/2/2013 JMP Securities New Coverage Market Perform
(N/A)
N/A
(N/A)
8.78 7.39 -15.83% Details
8/30/2012 Stifel Nicolaus New Coverage Hold
(N/A)
N/A
(N/A)
6.92 7.39 6.79% Details